The Uncertainty Shrouding Argentina’s Antiaftosa Vaccine Campaign
As Argentina approaches the commencement of its antiaftosa vaccination campaign, a cloud of uncertainty looms over the livestock sector. The primary concern is the mystery surrounding the prices of the vaccines, with key industry players remaining silent on anticipated costs. This year, only two companies—Biogénessis Bagó and Centro Diagnóstico Veterinario (CDV)—will be responsible for dispensing the vaccines needed for the more than 52 million livestock across the nation.
The Call for Transparency
The Federación de Asociaciones Rurales de Entre Ríos (Farer) has been vocal about the lack of pricing information from the vaccine manufacturers, expressing concerns about the lack of transparency. According to Farer, the unpredictability is further heightened by stable economic indicators, which should, in theory, facilitate easy cost calculations for each dose. Traditionally, the price of the vaccine in the Argentinian market has been around US$1 per dose—a figure that represents a significant economic volume, translating to approximately US$100 million.
Yet, there are whispers in the market about potential price increases, suggesting that laboratorio intentions might shift the vaccine cost to be equivalent to the kilogram price of calves or steers, which is currently over $3000. These rumors have caused producer dissatisfaction, sparking previous controversies regarding vaccine costs—deemed excessively high compared to neighboring countries.
Government and Industry Responses
In response to these controversies, the previous administration witnessed actions pushing for legislative changes to facilitate vaccine importation, with cases as early as last April sparking conversations at high-government levels. At that time, concessions saw prices being reduced from $1900 to $1400 after public interventions. The current framework allows vaccine importation, although this provision hasn’t yet been fully realized in practice.
Significantly, industry stakeholders emphasize the role of vaccine-producing foundations in driving large-scale purchases, thereby bearing a substantial influence on pricing. According to Nicasio Tito, president of Farer, “The vaccine has no price [settled], leading to unprecedented strategic delays.” Entities like Fucofa and Fucosa are embroiled in these discussions, managing budget allocations for vaccine procurement.
Future Trends in Vaccination Strategies
Looking forward, a significant discussion among industry entities revolves around potential shifts in vaccination strategies. The aim is to reduce costs by possibly excluding certain animal categories—such as novillitas and vaquillonas—from the annual vaccination cycle, akin to strategies employed by Uruguay and Paraguay.
A move towards a more cost-effective model while ensuring sanitary safety remains a priority. “We’re not advocating for the cessation of vaccinations but adapting the approach to provide economic relief without compromising sanitary standards,” says Fernando Ferrari of Carbap.
Anticipated Adjustments and Stakeholder Engagement
Meanwhile, an update from Fernando Matticoli, Director Comercial of CDV, suggests upcoming price adjustments are under consideration. “We are aware of the sector’s alertness and are evaluating price adjustments based on production costs and market conditions,” Matticoli stated, expressing a commitment to transparent communication in the impending days.
FAQs
Q: Why is there uncertainty about vaccine pricing?
A: Lack of communication from vaccine manufacturers and the absence of confirmed price details is cultivating industry-wide uncertainty.
Q: Could livestock categories change in vaccine protocols?
A: There is a proposition to exclude certain categories to reduce costs while maintaining sanitary safety, similar to the approach of neighboring countries.
Q: How is the government involved?
A: The government is facilitating processes for vaccine importation, which may help stabilize prices.
Did You Know?
Historically, the antiaftosa vaccination campaign stabilizes Argentina’s livestock export capacity, influencing its meat industry trade balance significantly.
Pro Tip
Stay informed about policy shifts surrounding livestock vaccinations as they may offer financial relief and strategic insights.
Get Involved
Join the conversation—comment below on how these trends might affect the broader meat export industry. For more insights and updates, consider subscribing to our newsletter.